F18.28
Inhalant dependence with other inhalant-induced disorders
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F18.28 describes a condition where an individual is dependent on inhalants and experiences additional disorders caused by inhalant use. Inhalants are substances that produce chemical vapors, which, when inhaled, can alter mental state. Dependence on these substances can lead to serious health complications, further complicated by other inhalant-induced disorders. Understanding this condition involves recognizing its causes, symptoms, diagnostic process, and available treatments.
Causes & Symptoms
Clinical Causes: Prolonged or repeated inhalant use leading to physical and psychological dependence Use of inhalants as a means to achieve a quick high due to their accessibility and low cost Psychological factors, such as mental health disorders, that increase vulnerability to substance dependence Environmental influences, including peer pressure and availability of substances Lack of awareness regarding the dangers of inhalant use
Key Symptoms: Craving or a strong desire to use inhalants Inability to control or stop inhalant use despite negative consequences Tolerance, requiring increased amounts to achieve the same effect Withdrawal symptoms upon cessation, such as sweating, tremors, irritability, or nausea Neglect of responsibilities and personal care Social withdrawal and continued use despite health or social problems Physical signs like chemical odors, paint or solvent residues on clothing or breath
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a detailed clinical assessment where healthcare providers evaluate a person’s substance use history, signs of dependence, and presence of inhalant-induced disorders. Diagnostic tools may include structured interviews and laboratory tests to detect inhalant metabolites. The clinician will assess for physical symptoms, psychological dependence, and any related health complications, ensuring a comprehensive understanding of the individual's condition.
Treatment Protocols: Treatment typically includes a combination of approaches tailored to address dependence and associated disorders. Common components comprise: - **Detoxification**: Medical supervision may be necessary to manage withdrawal symptoms safely. - **Counseling and therapy**: Behavioral therapies, such as cognitive-behavioral therapy (CBT), aim to modify harmful thought patterns and develop coping strategies. - **Support groups**: Peer support can be vital in preventing relapse and maintaining sobriety. - **Addressing co-occurring conditions**: Treatment of any underlying mental health issues that may contribute to inhalant use. - **Family and social support**: Engaging family and social networks can reinforce recovery efforts. Since inhalant dependence can have severe health effects, ongoing monitoring and support are often essential for sustained recovery.
Clinical Advice & FAQs
Billing Guidance
Is F18.28 a billable ICD-10 code?
Yes, F18.28 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.28?
Clinical documentation must specify the nature of Inhalant dependence with other inhalant-induced disorders and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
